Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.96+0.03 (+0.76%)
Close on Nov 20, 2026Market cap $317.61MP/E –Yield –
Atea Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Atea Pharmaceuticals's revenue for the twelve months ending Dec 31, 2021 was $351.37M. For fiscal 2021 it was $351.37M, up 622.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $351.37M | +622.5% |
| FY2020 | Dec 31, 2020 | $48.63M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $192.18M | – |
| Q3 FY2021 | Sep 30, 2021 | $32.81M | – |
| Q2 FY2021 | Jun 30, 2021 | $60.39M | – |
| Q1 FY2021 | Mar 31, 2021 | $65.99M | – |
See a number that looks wrong?